1) Capucci A, Santini M, Padeletti L, et al:Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 46:1913-1920, 2005
2) Glotzer TV, Daoud EG, Wyse DG, et al:The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk:The TRENDS Study. Circ Arrhythm Electrophysiol 2:474-480, 2009
3) Boriani G, Glotzer TV, Santini M, et al:Device-detected atrial fibrillation and risk for stroke:an analysis of >10000 patients from the SOS AF project(Stroke prevention strategies based on atrial fibrillation information from implanted devices). Eur Heart J 35:508-516, 2014
4) Cesario DA, Powell BD, Cao M, et al:Atrial fibrillation and outcomes in a large cohort of CRT recipients:results from the ALTITUDE Study. J Am Coll Cardiol 57:E153, 2011
5) Binici Z, Intzilakis T, Nielsen OW, et al:Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation 121:1904-1911, 2010
6) de Vos CB, Pisters R, Nieuwlaat R, et al:Progression from paroxysmal to persistent atrial fibrillation. Clinical correlates and prognosis. J Am Coll Cardiol 55:725-731, 2010
7) Steinberg BA, Hellkamp AS, Lokhnygina Y, et al:Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation:results from the ROCKET-AF Trial. Eur Heart J 36:288-296, 2015